NATIXIS - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 54 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
NATIXIS ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$504,589
+7.9%
31,1860.0%0.00%0.0%
Q2 2023$467,790
+5.3%
31,1860.0%0.00%0.0%
Q1 2023$444,401
+25.5%
31,186
+19.1%
0.00%
+100.0%
Q4 2022$354,03526,1860.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders